Evidence database

Best practice portal main page

Opioid substitution treatment (OST) to improve HCV treatment outcomes

Summary of the evidence

Rating
  • Unknown effectiveness

Opioid Substitution Treatment (OST) to increase compliance to HCV treatment and to  to increase HCV treatment virological response  were considered not possible to assess due to the lack of ad-hoc studies in a synthesis based on a narrative review (Hellard et al., 2009, cited in EMCDDA - ECDC 2011) including 30 observational studies with a total number of patients superior to 4,000.

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option
  • Hepatitis C treatment
Desired outcome(s)
  • improve treatment outcomes
Area(s)
  • Harm reduction
Specific substance or pattern of use
  • amphetamines
  • opioids
Target group(s) or setting(s)
  • PWID – people who inject drugs

References

Explore all resources in the Best practice portal

 

Miniguides

A one-stop-shop for anyone planning or delivering health and social responses.

 

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

 

Evidence

All of the latest research and evidence on drug-related interventions.

 

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

About the Best practice portal

Collaborations and partnerships in best practice

Logo of the Cochrane Collaboration
Logo of the Campbell Collaboration
Grade logo
WHO logo
Top